Figure 1From: High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014 Timing of the administration of the 4th and 5th IV boluses of IL-2 is plotted versus systolic and diastolic blood pressure and heart rate. This patient shows characteristic exacerbation of hypertension 3-4 hours after infusion responsive to fluid boluses.Back to article page